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Abstract
BK polyomavirus-associated haemorrhagic cystitis (BKHC) is 
a complication after allogeneic stem cell transplantation, 
which can occur in 5–60% of the cases. BK viruria alone can 
also occur in up to 100%. BKHC can lead to severe morbidity 
in stem cell-transplanted patients, but data about this dis-
ease is limited. Consequently, we conducted a prospective 
unicentric non-interventional trial on BKHC as well as BK viru-
ria after first adult allogeneic stem cell transplantation with a 
follow-up time of 1 year after inpatient treatment. Between 
November 2013 and December 2015, we were able to in-
clude 40 adult patients with a mean age of 52.8 years. Twen-
ty-seven (67.5%) of these patients were male and 13 (32.5%) 
were female. Acute myeloid leukaemia was the most fre-
quent underlying disease (n = 15; 37.5%). Only 1 patient de-
veloped BKHC during inpatient treatment (n = 1; 2.5%), but 
BK viruria was frequent (n = 11; 27.5%) during inpatient treat-
ment as well as in the follow-up time (n = 14; 35%). Interest-
ingly, BK viruria was significantly associated with mucositis 
(p = 0.038) and number of transfused platelet concentrates 
(p = 0.001). This unexpected association will be discussed and 
needs further investigation. © 2019 S. Karger AG, Basel
Introduction
Every year, 50,000 patients receive a stem cell trans-
plantation worldwide, but there is a lack of data about 
urological complications that can occur after transplanta-
tion. So far, most studies had been performed in paediat-
ric stem cell transplantations or are retrospective analyses 
with a small number of cases. The complications men-
tioned were mostly urological infections and haematuria 
[1]. Another complication that arises under this therapy 
is the BK polyomavirus-associated haemorrhagic cystitis 
(BKHC), which can occur in 5–60% of the cases [2]. BK 
viruria alone can also occur in up to 100%. Hence, re-
search on this issue is of high clinical significance as 
BKHC can lead to severe morbidity or even mortality in 
stem cell-transplanted patients [3, 4]. 
In another retrospective study with 2,477 patients after 
allogeneic stem cell transplantation, symptomatic BK 
viruria was also significantly associated with an impair-
ment of kidney function and worse overall survival [5]. 
Nearly the same had been described before by Gilis et al. 
[6]. Despite the fact that BK viruria and its complications 
can be severe and lead to patient morbidity, no causal 
therapy has been established yet. 
Consequently, we conducted a prospective unicentric 
non-interventional trial on urological complications with 





logeneic stem cell transplantation with a follow-up time 
of 1 year (after the end of inpatient treatment). One of the 
endpoints was to identify associations of BK viruria with 
main clinical and outcome parameters like overall sur-
vival; thus, we report the most interesting results of this 
evaluation for clinical practice. 
Materials and Methods
This is a prospective unicentric non-interventional trial. Before 
starting the study, we obtained the approval of the local ethics re-
view board at the University Medicine in Greifswald (BB 116/13 
from October 8, 2013). The inclusion criteria were patients aged 
over 18 years receiving their first allogeneic stem cell transplanta-
tion due to haematological disease. The use of low-dose alemtu-
zumab (10 mg at day –2; 20 mg in case of a mismatch) for graft 
versus host disease prophylaxis was mandatory. No exclusion cri-
teria were defined. From November 2013 until December 2015, we 
were able to include 40 patients in our study. Statistical calcula-
tions were made using SPSS 24.0 (SPSS Inc., Chicago, IL, USA). BK 
virus load was measured using quantitative PCR (LightMix Poly-
oma JC-BK, manufacturer Tib Molbiol, Germany). All reported p 
values were based on a two-sided hypothesis; p < 0.05 was consid-
ered to be significant.
Results
Between November 2013 and December 2015, we were 
able to include 40 adult patients with a mean age of 52.8 
years. Twenty-seven (67.5%) of these patients were male 
and 13 (32.5%) were female. Acute myeloid leukaemia 
was the most frequent underlying disease (n = 15; 37.5%). 
The majority of the patients received intermediate in-
tense conditioning protocols (n = 31; 77.5%). BKHC oc-
curred quite seldom: only 1 patient developed this disease 
during inpatient treatment (n = 1; 2.5%), but BK viruria 
was frequent (n = 11; 27.5%) during inpatient treatment 
as well as in the follow-up time (n = 14; 35%). 
Interestingly, BK viruria was significantly associated 
with mucositis (p = 0.038; Fisher exact test), the number 
of transfused platelet concentrates (p = 0.001; t test), and 
the duration of inpatient treatment (p = 0.048; t test). 
Contrary to our expectations, BK viruria as well as mu-
cositis were not significantly associated with myeloabla-
tive conditioning (Fisher exact test). 
The median overall survival time was 20.0 months 
(IQR 12.25–28.75 months). Figure 1 shows the Kaplan-
Meier plot of overall survival. In log rank testing, there 
was no significant difference of overall survival in both 
groups with or without BK viruria (p = 0.977; log rank). 
Discussion
We conducted a prospective unicentric non-interven-
tional trial about urological complications after first adult 
allogeneic stem cell transplantation with a focus on BK 
virus. To our knowledge, this is one of the first studies 
specifically addressing this topic. 
In our opinion, the most interesting result of this eval-
uation is the significant association of BK viruria with 
mucositis. The association of asymptomatic BK viruria 
with mucositis has been described before in a retrospec-
tive study of Peterson et al. [7]. Although this association 
has been demonstrated before, an explanation is not obvi-
ous.
There are two possible explanations for this unexpect-
ed but confirmed association: first, a direct causal rela-
tionship or, second, the presence of a common confound-
er. Both, mucositis and BK viruria may be influenced by 
the degree of epithelial damage induced by the condition-
ing therapy. In this case, you would expect to see an as-
sociation between BK viruria and/or mucositis and my-
eloablative conditioning (which is believed to induce the 
greatest epithelial damage), but at least in our study this 
association could not be demonstrated.
Another possible link may be the intensity of immu-
nosuppression induced by immunosuppressive drugs 
(e.g., cyclosporine A), T-cell depleting antibodies (e.g., 
ATG or alemtuzumab) or the conditioning regimen itself. 























Fig. 1. Kaplan-Meier plot of overall survival of the study popula-
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BK replication more often, but reactivation of other vi-
ruses contributing to mucositis (e.g., herpes simplex vi-
rus) may also be promoted. As the extent of immunosup-
pression is difficult to quantify, this association may be 
difficult to prove without a definition of a valid surrogate 
parameter.
Looking for a direct causal relationship between BK 
viruria and mucositis, you may speculate about the pos-
sibility that BK virus may reactivate in the epithelium in 
general and BK virus may also be found in oral mucositis. 
As nobody has addressed this question so far, further in-
vestigations will be of interest. 
In addition, our study demonstrates a strong associa-
tion between BK viruria and the number of transfused 
platelet concentrates. On the one hand, this association 
can be explained by the patient with BKHC who received 
17 platelet concentrates during therapy of his BKHC. On 
the other hand, BK viruria (without BKHC) is often ac-
companied by a mild microhaematuria only detectable by 
urinalysis, representing a subclinical BK cystitis not lead-
ing to macrohaematuria, but strong enough to induce a 
consumption of platelets by a localized activation of the 
coagulation system at the bladder surface. Consequently, 
we have to further analyse these cases of microhaematuria 
with a focus on virus replication and blood counts. Ad-
ditionally, platelet consumption can also occur in muco-
sitis even when it is happening at the same time as BK 
viruria. 
On the whole, we suggest with these data that BK re-
activation might occur as a generalized problem in the 
epithelium; however, further investigations of the asso-
ciation of BK virus and mucositis are necessary, e.g., the 
analysis of pharyngeal washes with quantitative PCR on 
BK virus replication. 
Furthermore, even if this is one of the first prospective 
studies, we assume that our data have some limitations 
such as the unicentric study population. The association 
of BK viruria with mucositis and maybe an occult blood 
loss is new and very interesting.
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